Ginkgo Bioworks Holdings Inc reports results for the quarter ended in March - Earnings Summary

Ginkgo Bioworks Holdings

09/05/2024 22:43

* Ginkgo Bioworks Holdings Inc  DNA.N  reported a quarterly
adjusted loss of 8 cents​​ per share for the quarter ended in
March, higher than the same quarter last year, when the company
reported EPS of -11 cents.  The mean expectation of six analysts
for the quarter was for a loss of 8 cents per share. Wall Street
expected results to range from -10 cents to -8 cents per share.
    * Revenue fell 53% to $37.94 million from a year ago;
analysts
expected $46.04 million. 
    * Ginkgo Bioworks Holdings Inc's reported EPS for the
quarter was
a loss of 8 cents​.
    * The company reported a quarterly loss of $165.91 million.
    * Ginkgo Bioworks Holdings Inc shares had fallen by 23.0%
this
quarter and lost 47.1% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 1.6%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 4
"hold" and 2 "sell" or "strong sell." 
    * Wall Street's median 12-month price target for Ginkgo
Bioworks
Holdings Inc is $2.00 

This summary was machine generated from LSEG data May 9 at 09:43
p.m. UTC. ​All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -0.08          -0.08          Met
 Dec. 31 2023      -0.10          -0.11          Missed
 Sep. 30 2023      -0.09          -0.16          Missed
 Jun. 30 2023      -0.08          -0.09          Missed